Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ESPR - Esperion Therapeutics, Inc.
164 K
LAST VALUE
-48.23%
2 YEAR CAGR
-9.15%
5 YEAR CAGR
8.80%
10 YEAR CAGR